medigraphic.com
SPANISH

Ginecología y Obstetricia de México

Federación Mexicana de Ginecología y Obstetricia, A.C.
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2022, Number 06

<< Back Next >>

Ginecol Obstet Mex 2022; 90 (06)

Retroperitoneal parasitic leiomioma: A case report

Velasco-García A, González-Muñoz A, Barrios JÁ, Mendoza-Quevedo J
Full text How to cite this article

Language: Spanish
References: 8
Page: 538-542
PDF size: 296.54 Kb.


Key words:

Parasitic leiomyoma, Uterine miomatosis, Retroperitoneal mass, Aromatase inhibitors, Gonadotropin-release hormone analogues.

ABSTRACT

Background: Parasitic leiomyomas are a rare entity, defined as an unusual variant of uterine myomatosis. Have been documented in the abdominal wall, small intestine, cervical or vaginal stump, iliac vessels, ovaries, sigmoid colon, and greater omentum.
Objective: To report a clinical case of retroperitoneal parasitic leiomyoma and review the literature.
Clinical case: A 57-year-old patient with a diagnosis of CIN-III and secondary abnormal uterine bleeding, who consulted for a sensation of abdominal mass and pain, subjective weight loss, hyporexia, dysphagia and gastric fullness, of four months of evolution. Extension studies document a large retroperitoneal mass and elevation of tumor markers Ca 125 and Ca 19-9. We practice surgical management of her gynecological pathology and resection of the mass by laparotomy, with histopathological finding of myoma.
Conclusion: Parasitic leiomyomas should be suspected in patients with a detected mass and a history of hysterectomy or myomectomy, especially in the context of morcellation. The treatment of this condition is surgical and, in cases of disseminated peritoneal leiomyomatosis, pharmacological treatments have been used with aromatase inhibitors and gonadotropin-release hormone analogues.


REFERENCES

  1. Barnaś E, Raś R, Skręt-Magierło J, Wesecki M, et al. Naturalhistory of leiomyomas beyond the uterus. Medicine (Baltimore)2019; 98 (25): e15877. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636938/

  2. Lete I, González J, Ugarte L, Barbadillo N, et al. Parasiticleiomyomas: a systematic review. Eur J Obstet GynecolReprod Biol 2016; 203: 250-9. doi: 10.1016/j.ejogrb.2016.05.025

  3. Barnaś E, Książek M, Raś R, Skręt A, et al. Benign metastasizingleiomyoma: A review of current literature in respectto the time and type of previous gynecological surgery.PLoS One 2017; 12 (4): e0175875.https://www.researchgate.net/publication/316287010_Benign_metastasizing_leiomyoma A_review_of_current_literature_in_respect_to_the_time_and_type_of_previous_gynecological_surgery

  4. Pacheco-Rodriguez G, Taveira-DaSilva AM, Moss J. BenignMetastasizing Leiomyoma. Clin Chest Med 2016; 37 (3):589-95. https://doi.org/10.1016/j.ccm.2016.04.019

  5. Steiner PE. Metastasizing fibroleiomyoma of the uterus:Report of a case and review of the literature. Am J Pathol1939; 15 (1): 89-110.7. https://www.wikidata.org/wiki/Q35972072

  6. Li J, Dai S. Leiomyomatosis Peritonealis Disseminata:A Clinical Analysis of 13 Cases and Literature Review.Int J Surg Pathol 2020; 28 (2):163-8. https://doi.org/10.1177/1066896919880962

  7. Wang X, Ren J, Chen G, Xu S. Giant abdominal leiomyomaof male: a case report and literature reviews. Int J Clin ExpPathol 2015; 8 (7): 8532-5.

  8. Fasih N, Prasad-Shanbhogue AK, Macdonald DB, Fraser-Hill MA, et al. Leiomyomas beyond the uterus: unusuallocations, rare manifestations. Radiogr a Rev Publ RadiolSoc North Am Inc 2008; 28 (7): 1931-48. https://doi.org/10.1148/rg.287085095




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Ginecol Obstet Mex. 2022;90